INSIGHTi
International COVID-19 Data and Vaccine
Distribution: Selected Resources
Updated December 2, 2021
The ongoing Coronavirus Disease 2019 (COVID-19) pandemic has caused mil ions of cases and deaths,
according to the World Health Organization (WHO). The resources below provide information on
tracking the international spread of the virus and global efforts to control it through vaccine distribution,
diagnostic supplies, and therapeutics.
These resources are not a comprehensive list of global COVID-19 data sources. They are a starting point
that may help congressional staff find resources for frequently requested data. Some links may work best
with the internet browsers Chrome and Firefox.
Readers may consider using caution when comparing data across sources, time frames, and geographies,
as each resource may have differing methodologies and definitions that may change over time. For
assistance in interpreting or analyzing these data, congressional staff may reach out to the Congressional
Research Service (CRS) (202-707-5700, or place a research request at the CRS website).
For more information concerning global COVID-19 vaccine distribution, please see CRS In Focus
IF11796, Global COVID-19 Vaccine Distribution, coordinated by Sara M. Tharakan; for an overview of
data resources concerning COVID-19 cases, hospitalizations, and deaths in the United States, please see
CRS Report R46642, COVID-19 Cases, Hospitalizations, and Deaths: Selected Resources for National,
State, and Local Data, by Angela Napili and Ada S. Cornel .
International COVID-19 Access to COVID-19 Tools
Accelerator
In April 2020, the WHO and partners launched the Access to COVID-19 Tools Accelerator (ACT-A) to
accelerate the development, production, and distribution of COVID-19 diagnostics, therapeutics, and
vaccines. Other collaborating institutions include Gavi (the Vaccine Al iance), the Coalition for Epidemic
Preparedness and Innovation (CEPI), the Global Fund to Fight HIV, Tuberculosis and Malaria, the World
Bank, the Bil & Melinda Gates Foundation, FIND (the Global Al iance for Diagnostics), Unitaid, and
Wel come. The ACT-A website provides more information, including
Congressional Research Service
https://crsreports.congress.gov
IN11732
CRS INSIGHT
Prepared for Members and
Committees of Congress
Congressional Research Service
2
Country Readiness and Delivery for Vaccines and
Country Readiness and Delivery Frequently Asked Questions.
COVAX is the vaccines pil ar of the ACT-Accelerator. It aims to accelerate the development and
manufacture of COVID-19 vaccines and guarantee fair and equitable access for every country in the
world. COVAX is co-led by CEPI, Gavi, and WHO, alongside its key delivery partner, the United Nations
Children’s Fund (UNICEF). In the Americas, the Pan American Health Organization (PAHO) Revolving
Fund is the recognized procurement agent for COVAX. The WHO-hosted COVAX website provides more
information on COVAX, including
COVID-19 Vaccine Introduction Toolkit and
Guidance on developing a national deployment and vaccination plan (NDVP). This
second edition of the guidance, updated June 2021, provides new information on several
topics, including
the availability and use of the WHO-UNICEF COVID-19 Vaccine Introduction
and deployment Costing (CVIC) tool;
the COVAX Facility’s humanitarian buffer that enables al ocation of vaccine to
cover high-risk populations in humanitarian settings;
the use of geospatial data and digital micro plans for equitable access and
delivery of COVID-19 vaccines.
International COVID-19 Tracking
The following U.S. and international organizations provide tools for tracking COVID-19 in countries and
regions worldwide, including COVID-19 case and death numbers, vaccination rates, and measures of the
socioeconomic and secondary impacts of COVID-19.
Centers for Disease Control and Prevention
The United States’ lead public health agency collects and tracks the following international data by
country using its COVID Data Tracker:
COVID-19 cases and deaths, counts, and rates;
Percentage change in COVID-19 cases and deaths reported in the past 7, 14, or 30 days;
Epidemic curve trajectory classification; and
Vaccine doses administered and people vaccinated, counts and rates.
Humanitarian Data Exchange
Run by the United Nations Office for the Coordination of Humanitarian Affairs (OCHA), the
Humanitarian Data Exchange’s (HDX’s) COVID-19 Data Explorer: Global Humanitarian Operations
offers daily and monthly “snapshots” of global humanitarian operations relating to COVID-19, socio-
economic risks, and vaccine distribution. It also provides an interactive tool for exploring international
COVID-19 data in combination with other relevant humanitarian data such as
COVID-19 Vaccine Roll-Out,
People in need,
School closures, and
Congressional Research Service
3
Vaccine Financing.
The World Bank
The World Bank’s Understanding the Coronavirus (COVID-19) Pandemic through Data website offers a
series of interactive datasets on the effects of COVID-19 worldwide, including, but not limited to,
COVID-19 vs. other causes of death (see right-most tab on the chart, “Understanding the
COVID-19 Pandemic through Data”);
Impacts of coronavirus on foreign remittances; and
Financial-sector support measures in response to the coronavirus.
World Health Organization
The WHO’s Coronavirus (COVID-19) Dashboard includes data on confirmed COVID-19 cases and
deaths by country and region, vaccines in use by country, and persons partly or fully vaccinated by
country.
International COVID-19 Vaccine Development and
Distribution Tracking
The following websites provide tools focused on tracking the development, production, and distribution
(i.e., shipments and deliveries) of COVID-19 vaccines in countries and regions worldwide.
Gavi, the Vaccine Alliance
Gavi is part of COVAX, the vaccines pil ar of the ACT-Accelerator. Gavi’s vaccine roll-out page al ows
users to explore vaccination status by country, including the date of the first doses received in each
country, the type(s) of al vaccines received, and the number of doses al ocated. For more information on
Gavi and U.S. immunization programs, please see CRS Report R46633, COVID-19 Vaccines: Global
Health Issues, coordinated by Sara M. Tharakan.
Department of State
The United States has committed to donating more than 1.1 bil ion doses of COVID-19 vaccines. The
State Department’s website tracks the status of the donation in total and by region and country.
Kaiser Family Foundation
The Kaiser Family Foundation has created a data visualizations website, using Department of State data
on the United States’ pledge to donate over 1.1 bil ion COVID-19 vaccine doses. Useful graphics include
Recipients of U.S. COVID-19 Vaccine Donation Deliveries by Total Doses Received,
U.S. COVID-19 Vaccine Donation Deliveries by Income,
U.S. COVID-19 Vaccine Donation Doses Delivered by Vaccine Product, and
Top Recipients of U.S. COVID-19 Vaccine Donation Deliveries by Total Doses Received.
Congressional Research Service
4
UNICEF
UNICEF’s Vaccine Market Dashboard provides updated information on
COVID-19 vaccine development and progress toward vaccine approvals,
Reported global vaccine production capacity,
Manufacturing agreements,
Vaccines secured and optioned through bilateral and multilateral supply agreements, and
Reported vaccine prices.
Author Information
Hannah Fischer
Information Research Specialist
Disclaimer
This document was prepared by the Congressional Research Service (CRS). CRS serves as nonpartisan shared staff
to congressional committees and Members of Congress. It operates solely at the behest of and under the direction of
Congress. Information in a CRS Report should not be relied upon for purposes other than public understanding of
information that has been provided by CRS to Members of Congress in connection with CRS’s institutional role.
CRS Reports, as a work of the United States Government, are not subject to copyright protection in the United
States. Any CRS Report may be reproduced and distributed in its entirety without permission from CRS. However,
as a CRS Report may include copyrighted images or material from a third party, you may need to obtain the
permission of the copyright holder if you wish to copy or otherwise use copyrighted material.
IN11732 · VERSION 4 · UPDATED